Olivier Rascol on amantadine for patients wit...

In this episode of In Conversation With, Morgane Boillot, Senior Editor at The Lancet Neurology, speaks with connective tissue disorders — including Marfan syndrome — and human genetics expert Hal Dietz from Johns Hopkins Medicine (Baltimore, USA) about the genetics of spontaneou ...  Show more

In this episode of In Conversation With, Elena Becker-Barroso, Editor-in-Chief of The Lancet Neurology, speaks with movement disorders specialist Tony Schapira from UCL’s Queen Square Institute of Neurology about GBA1-associated Parkinson’s disease. Together, they explore the gen ...  Show more

Dr. Jason Crowell talks with Prof. Bastiaan Bloem about the latest developments in biomarkers and treatments for movement disorders, which have been described in numerous research papers from 2022. 

Read the related article in <a href= "https://www.thelancet.com/journal ...

Dr Alex Thompson, honorary consultant neurologist at Oxford University Hospitals NHS Trust, joins Sam for today's episode looking at motor neurone disease in PACES. We talk through the history, examination signs, differential diagnoses, investigations and management of this condi ...  Show more

We begin with a discussion about our article of the week which comes from The Lancet and is entitled “Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-c ...

Dr. Alison Christy talks with Dr. Tatjana Bremova-Ertl about the use of N-acetyl-L-leucine in pediatric and adult patients with GM2 gangliosidoses.

Read the related article in Ne ...